@dviceST @dub_k1 How many times did the KOL's at the $PDSB event have to say it during the KOL event? @adamfeuerstein listened to the event but conveniently forgot they mentioned it.
Finally read this clowns poor attempt at a hit piece on $PDSB. His main point that he keeps repeating is that cross trial comparisons can’t be done & company is wrong for sharing historic data. I’ve never seen a company present phase 2 data without showing historical data.
PDS Biotech Announces Plan to Initiate Phase 3 Study Evaluating PDS0101 in Combination with KEYTRUDA® in Head and Neck Cancer in 2023 $PDSB
https://t.co/KU7Pf50VwP
Any body new on Twitter and new to the #silversqueeze ?? Retweet this post and drop a follow. I’ll follow you back. Also follow everyone who likes and retweets this tweet. We are a family. #silverbacks#silver#silversqueeze